Alnylam Pharmaceuticals (ALNY) Q1 2021 Earnings

11FebConfirmed
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-2.18
-1.97
-1.77
-1.56

Details

Expected EPS
-1.79
Actual EPS
-2.09
Surprise EPS
-0.3
Surprise Percent
+16.76%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -2.09 per share for Q1 2021.

0 Comments

Share your thoughts